← All diseases
Lungs and airways
Cystic fibrosis
Do you want to receive a message when there is new research about cystic fibrosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication there is one sentence that explains what was studied — and you receive notification as soon as there is new research on Cystic Fibrosis. View what Premium costs.
Publications and studies (2552)
- Biofilm-associated reduced antimicrobial susceptibility in Pseudomonas aeruginosa isolates from cystic fibrosis patients: MIC-MBEC discordance. (2026/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical Guidance on the Safe Use of Sodium-Glucose Cotransporter Inhibitors in Adults with Type 1 Diabetes. (2026/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Type 1 Diabetes Management Beyond Insulin: Aligning Evidence, Research, and Regulation. (2026/09/01) ♡
- Impaired Renal Base Excretion in Secretin Receptor Knock-Out Mice During Prolonged Base-Loading. (2026/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Potassium Channels of the Airway Epithelium. (2026/09/01) ♡
- An Integrated Quality by Design RP-UPLC Method for Lumacaftor and Ivacaftor in Human Plasma. (2026/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Bronchiectasis with elevated liver enzymes and pancreatic exocrine insufficiency]. (2026/08/12) ♡
- Adrenaline Use and Request for Emergency Medical Assistance to Manage Food Anaphylaxis. (2026/08/11) ♡
- Early Endoscopic Repair of Traumatic Skull Base Dural Injuries: Challenging the Dogma of Conservative Management. (2026/08/11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Mental health, sleep, and quality of life following CFTR modulator therapy: a longitudinal study of children with cystic fibrosis and caregivers. (2026/08/11) ♡
- T cell-intrinsic AIM2 exacerbates lung inflammation in OVA-LPS- and HDM-induced asthma models. (2026/08/11) ♡
- Sinusitis and Olfaction Improve in Young Children with Cystic Fibrosis Treated with ETI. (2026/08/10) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Preventive intrapulmonary treatment with Ligilactobacillus murinus reduces airway inflammation and mucus plugging in mice with cystic fibrosis-like lung disease. (2026/08/10) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Ins and outs of anti-Aspergillus serology in chronic pulmonary aspergillosis: a narrative review. (2026/08/10) ♡
- Cystic fibrosis in 2026: Game over, or game on? Introduction to an AJRCCM special section on cystic fibrosis. (2026/08/10) ♡
- Genomic insights into efflux-mediated biofilm persistence and multidrug resistance in Achromobacter xylosoxidans from cystic fibrosis. (2026/08/10) ♡
- Dysregulated Ferritin and Iron Homeostasis in Autosomal Dominant Polycystic Kidney Disease. (2026/08/09) ♡
- An Injury-Conforming Dual-Layer Lung Sealant. (2026/08/08) ♡
- Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies. (2026/08/07) ♡
- Functional specialization of mPFC-BLA and mPFC-NAc pathways in affective state representation. (2026/08/07) ♡
- Discovery of Staphylococcus aureus small RNAs highly expressed during human chronic infection. (2026/08/07) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nutrition and cardiometabolic health in cystic fibrosis: Emerging evidence and research gaps. (2026/08/07) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Growing Staphylococcus aureus in synthetic cystic fibrosis medium promotes colonization in a murine pneumonia model. (2026/08/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cystic fibrosis-associated amyloid a amyloidosis: a rare but devastating complication with poor prognosis. (2026/08/06) ♡
- Developing consensus on rare disease care pathways and ERN integration across Europe: insights from stakeholder workshops and a Delphi study. (2026/08/06) ♡
- Correlation between pulmonary outcomes and nutritional status following treatment with elexacaftor/tezacaftor/ivacaftor in people with Cystic fibrosis. (2026/08/06) ♡
- Preclinical models of COPD: a state of the art. (2026/08/06) ♡
- A Suspected Case of Allergic Bronchopulmonary Mycosis Associated With Exophiala dermatitidis. (2026/08/06) ♡
- Pulmonary Outcomes in People with Cystic Fibrosis who Stop Chronic Daily Therapies: The HERO-2 Study. (2026/08/05) ♡
- Complicated Acute Rhinosinusitis in Cystic Fibrosis: National Inpatient Pediatric Analysis. (2026/08/05) ♡
- Implementation and outcomes of drug response assessments for inhaled hypertonic saline in bronchiectasis: a post hoc analysis of the CLEAR trial. (2026/08/05) ♡
- Unsupervised home spirometry versus supervised clinic spirometry: analysis of longitudinal participant-level data from the CLEAR trial in patients with bronchiectasis. (2026/08/05) ♡
- Psychological factors and functional capacity as determinants of health-related quality of life in bronchiectasis. (2026/08/04) ♡
- Within-Person Sweat Chloride Variability in People with Cystic Fibrosis Measured via Wearable Microfluidic Sticker. (2026/08/04) ♡
- Successful Rapid Desensitization to Ceftazidime/Avibactam in a Patient With Cystic Fibrosis and Multidrug-Resistant Pseudomonas aeruginosa Pneumonia: A Case Report. (2026/08/04) ♡
- The utilization of multiplex PCR with fragment analysis for carrier screening of spinal muscular atrophy. (2026/08/04) ♡
- Validation of claims-based algorithms for identifying selected interstitial lung disease (idiopathic interstitial pneumonias and drug-induced interstitial lung disease). (2026/08/04) ♡
- Clinical characteristics and outcomes of people with cystic fibrosis with homozygous minimal function genotypes compared to those with F508del/minimal function genotypes. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. DNA sequencing for microbial surveillance in cystic fibrosis airways: advances, challenges, and clinical translation. (2026/08/03) ♡
- Revision Endoscopic Sinus Surgery in Cystic Fibrosis With Chronic Rhinosinusitis: Before and After Cystic Fibrosis Transmembrane Conductance Regulator Triple Modulator Therapy. (2026/08/03) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Low-energy extracorporeal shock wave therapy is associated with reduced inflammation and fibrosis in an E(2)-induced rat model of endometriosis and remains effective under menopause-mimicking conditions. (2026/08/03) ♡
- Complex Genomic Rearrangement Involving the TBX4 Promoter Manifesting With Variable Expressivity in a Five-Generation Family. (2026/08/03) ♡
- Polymicrobial Extracellular Vesicles Reduce the Innate Immune Response of Human Cystic Fibrosis Bronchial Epithelial Cells. (2026/08/03) ♡
- De-escalation of Medications After Initiation of Elexacaftor-Tezacaftor-Ivacaftor in Children 6 to 11 Years of Age With Cystic Fibrosis. (2026/08/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Multidisciplinary Cystic Fibrosis Teams: First Steps to Improve Professional Quality of Life and Address Burnout. (2026/08/01) ♡
- Validation of Dried Blood Spot Immunoreactive Trypsinogen as a Biomarker of Exocrine Pancreas Function in Children With Pancreas Disease. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Contributors to the heterogeneity of response to CFTR modulators. (2026/08/01) ♡
- From bilirubin to breakthroughs: Contemporary outcomes in pediatric liver transplantation for cystic fibrosis. (2026/08/01) ♡
- People with cystic fibrosis' experience of symptom burden while taking elexacaftor/tezacaftor/ivacaftor. (2026/08/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.